Summary of Results
Endocrine, nutritional and metabolic
|Guidance:||Obesity - sibutramine|
|Description:||The summary of the withdrawn technology appraisal on Obesity - sibutramine. It links to the withdrawn guidance and key documents.|
NICE implementation uptake reports
|Implementation uptake report||Assessment||Published Date||Coverage|
Johnston A et al
A clinical audit to investigate the compliance of general practitioners to NICE guidelines for the prescribing of anti-obesity drugs sibutramine and orlistat.
International Journal of Pharmacy Practice
|Doubts about or mixed impact in practice||Local|
NICE guidance for anti-obesity medication: is it being followed?
Journal of Human Nutrition and Dietetics
|Practice appears not to be in line with guidance||National|
NICE guidance implementation tracking: data sources, methodology and results
|Practice appears to be in line with guidance||National|
This page was last updated: 28 August 2007